Skip to content

The Study on the Diagnostic Value of Cervical Spondylotic Myelopathy by Magnetic Resonance Spectrum

The Study on Magnetic Resonance Spectrum in diagnosis of Cervical Spondylotic Myelopathy

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-09000495
Enrollment
Unknown
Registered
2009-08-05
Start date
2007-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spondylotic Myelopathy

Interventions

Gold Standard:
Index test:

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. To be consistent with the diagnostic criteria for Cervical Spondylotic Myelopathy; or to meet the diagnostic criteria for asymptomatic and degenerative spinal compression; or volunteers to be healthy; 2. Male and female aged 20 to 70 years old.

Exclusion criteria

Exclusion criteria: 1. Functional lesions in major organs including heart, lung and brain with unstable vital signs; 2.Primary diseases from the merger of central nervous system such as multiple sclerosis, motor neuron disease, lateral sclerosis and cerebral apoplexy; 3. Diseases of extremities peripheral nerve such as lubar intervertebral disc protrusion, lumbar spinal stenosis, infantile paralysis, neurofibroma and neuritis; 4. Acute cervical spinal cord injury; tuberculosis infection ambury complicating cervical vertebra; 5. Prohibition of MR examination because of the patient's body containing metal; 6. Lunatics.

Design outcomes

Primary

MeasureTime frame
Sensitive and specificity;Japanese Orthopaedic Association (JOA) score;

Countries

China

Contacts

Public ContactHu Zhang
tiger728@126.com+86 135 3510 8397

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026